US Patent 9617328 Fusion protein having factor IX activity
Patent 9617328 was granted and assigned to SK Chemicals on April, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+267 characters)
Article
Patent abstract
Disclosed is a fusion protein comprising blood coagulation factor IX (FIX) and transferrin. The fusion protein exhibits improved specific FIX activity, as compared to native FIX, and can be useful in the treatment of FIX deficiency-associated diseases.
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Bong-yong Lee0
Hun-Taek Kim0
Mahn Hoon Park0
Min Sun Lee0
Yun Jung Lim0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09617328 Fusion protein having factor IX activity US Patent 9617328 Fusion protein having factor IX activity
Infobox
Patent Number
09617328
Patent Number
9617328
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09617328 Fusion protein having factor IX activity
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09617328
Date of patent
April 11, 2017
Patent application number
13880239
Date Filed
October 19, 2011
Patent primary examiner
Find more entities like US Patent 9617328 Fusion protein having factor IX activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.